从《胰腺癌综合诊治中国专家共识(2014)》发布看中国胰腺癌的规范化综合诊治
被引量:3
摘要
胰腺癌是全球公认的“癌中之王”,在我国,其发病呈快速上升趋势,尤以经济发达地区为高。据统计,中国胰腺癌患者占世界总数的15.68豫,发病率和死亡率均居恶性肿瘤前十位。目前我国胰腺癌的诊治存在医疗水平参差不齐、早诊率低、错诊率高、偏重外科手段、治疗水平不均衡不规范、治疗轻循证重经验、综合治疗的实施力度不够等问题,远期生存极不理想,迄今仍是临床难题。
出处
《浙江医学》
CAS
2014年第13期1125-1126,1136,共3页
Zhejiang Medical Journal
同被引文献34
-
1Han SS, Kim SW, Jang JY, et al. A comparison of the long- term functional outcomes of standard pancreatoduodenec- tomy and pylorus-preserving pancreatoduodenectomy [J]. Hepatogastroenterology, 2007, 54(78): 1831-1835.
-
2Jakobisiak M, Golab J. Statins can modulate effectiveness of antitumor therapeutic modalities [J]. Med Res Rev, 2010, 30(1): 102-135.
-
3Gazzerro P, Proto MC, Gangemi G, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer [J]. Pharmacol Rev, 2012, 64(1): 102-146.
-
4Ma S, Ma CC. Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily [J]. Cytokine Growth Factor Rev, 2011, 22(3): 167-175.
-
5Zhu Y, Casey P J, Kumar AP, Deciphering the signaling net- works underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Racl GTPases [J]. Cell Death Dis, 2013, 4: e568.
-
6Wood WG, Igbavboa U, Muller WE, et al. Statins, Bel-2, and apoptosis: cell death or cell protection? [J]. Mol Neurobiol,. 2013, 48(2): 308-314.
-
7Tu YS, Kang XL, Zhou JG, et al. Involvement of Chkl- Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells [J]. Eur J Pharmacol, 2011,670(2-3): 356-364.
-
8Mohammed A, Qian L, Janakiram NB, et al. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-Kras- G12D/+ mice [J]. Int J Cancer, 2012, 131(8): 1951-1962.
-
9Pelaia G, Gallelli L, Renda T, et al. Effects of statins and farnesyl transferase inhibitors on ERK phosphoryla-tion, apoptosis and cell viability in non-small lung cancer cells [J]. Cell Prolif, 2012, 45(6): 557-565.
-
10Alegret M, Silvestre JS. Pleiotropic effects of statins and re- lated pharmacological experimental approaches [J]. Methods Find Exp Clin Pharmacol, 2006, 28(9): 627-656.
引证文献3
-
1张敏,孔雁,姜达,程敏菊,郭治.普伐他汀对人胰腺癌细胞SW1990增殖和凋亡的影响及其机制研究[J].肿瘤药学,2016,6(1):49-53.
-
2柯法永,李茂岚,吴向嵩,刘颖斌,龚伟.胰腺癌肝转移外科治疗策略及进展[J].中华肝脏外科手术学电子杂志,2017,6(1):10-15. 被引量:2
-
3牛丽萍.胰腺癌术后肝转移发生状况及影响因素分析[J].中国实用医刊,2023,50(12):14-18.
二级引证文献2
-
1孔祥子,孙韶龙,王熠辉,金俊伊,彭洋,王宝胜.肝胰病灶同步切除治疗胰腺癌肝转移的安全性及对预后的影响[J].现代肿瘤医学,2020,28(9):1496-1502. 被引量:4
-
2李冬筱,潘玉进,丁向明,李德宇.胰腺癌肝转移的外科治疗进展[J].肝胆外科杂志,2022,30(6):414-417. 被引量:1
-
1魏永宝,宋伟,杨金瑞,朱梁,郭琼,戴澍,梁波罗.氯胺酮相关性泌尿系统损害的研究进展[J].中华泌尿外科杂志,2012,33(8):631-633. 被引量:3
-
2赵莎.浅谈抗生素的合理应用[J].邯郸医学高等专科学校学报,2004,17(6):503-504. 被引量:2
-
3史录文,陈薇,高秀云.我国医院开展临床药学工作状况的调查分析[J].中国药师,1998,1(1):36-38. 被引量:10
-
4赵红梅,刘越明,杜婷.概述我国农村药品市场情况及农村药店的发展趋势[J].辽宁医药,2008,23(2):28-30.
-
5罗惠灿.本院2013年处方管理及不合理用药情况探析[J].北方药学,2014,11(12):161-161.
-
6陈卫明,郭钻,施胜梅.本院2012年处方管理及不合理用药情况分析[J].中国乡村医药,2014,21(9):47-48. 被引量:1
-
7何瑾,龙晓东,普燕芳,张峻.云南省乡村医生抗菌药物、糖皮质激素认知及使用情况的调查分析[J].中国药房,2016,27(3):299-302. 被引量:12
-
8何航,傅德良.人类胰腺癌表达谱研究[J].国际外科学杂志,2010,37(11):769-774.
-
9陈丽昆,徐光川,管忠震,梁颖,杨群英.奈达铂或顺铂联合紫杉醇治疗晚期非小细胞肺癌的随机对照研究[J].中华肿瘤杂志,2007,29(6):437-440. 被引量:36
-
10钱家鸣,吴东.消化科医师在胰腺癌多学科诊疗中的作用[J].中华消化杂志,2017,37(1):4-6. 被引量:2